![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PHARMENG REPORTS EARNINGS FOR 2005
PHARMENG REPORTS EARNINGS FOR 2005
April 26, 2006
PharmEng International Inc., a full-service consulting and contract manufacturing company, today reported its results for the period ended December 31, 2005. For the twelve-month period ended December 31, 2005, the Company had revenues of $7,563,000 on a consolidated basis compared to $5,894,000 for the same period in the prior year, an increase of $1,669,000, or 28%. This increase was a result of the Company's continuing successful penetration into the U.S. market through the Raleigh, NC offices which opened in September 2005.
CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=591081)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct